Evidence map›Paper›PMID 24710016›Full record

ArticleNature communications2014

Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen.

Yusuke Yoshioka, Nobuyoshi Kosaka, Yuki Konishi, Hideki Ohta, Hiroyuki Okamoto, Hikaru Sonoda, Ryoji Nonaka, Hirofumi Yamamoto, Hideshi Ishii, Masaki Mori and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 275 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
275citing papers in PubMed, 1 pooled it
14.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

275 citing papers in PubMed, 1 synthesis or guideline pooled it, 592 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. A Dual-Channel Synergistic Ultrasensitive Biosensor for Tumor Liquid Biopsy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Rethinking Extracellular Vesicle Signaling.Advanced materials (Deerfield Beach, Fla.) · 2026
    Article
  12. Article
  13. Article
  14. Novel Liquid Biopsy in Gastrointestinal Cancers.Journal of gastroenterology and hepatology · 2026
    Review
  15. Article
  16. Article
  17. Role of Exosomal Non-Coding RNAsMicroRNA (Shariqah, United Arab Emirates) · 2026
    Review
  18. Review
  19. Review
  20. Review

215 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Yusuke Yoshioka1] Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo 104-0045, Japan [2] Integrative Bioscience and Biomedical Engineering, Graduate School of Advanced Science and Engineering, Waseda University, Shinjuku, Tokyo 162-8480, Japan [3] Research Fellow of the Japan Society for the Promotion of Science (JSPS), Chiyoda-Ku, Tokyo 102-0083, Japan.
Nobuyoshi KosakaDivision of Molecular and Cellular Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo 104-0045, Japan.
Yuki Konishi1] Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo 104-0045, Japan [2] R&D Department, SRL Inc., Hino-shi, Tokyo 191-0002, Japan.
Hideki OhtaDiagnostics Division, Shionogi & Co., LTD., Settsu-shi, Osaka 566-0022, Japan.
Hiroyuki OkamotoDiagnostics Division, Shionogi & Co., LTD., Settsu-shi, Osaka 566-0022, Japan.
Hikaru SonodaDiagnostics Division, Shionogi & Co., LTD., Settsu-shi, Osaka 566-0022, Japan.
Ryoji NonakaDepartment of Gastroenterological Surgery, Graduated School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Hirofumi YamamotoDepartment of Gastroenterological Surgery, Graduated School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Hideshi IshiiDepartment of Frontier Science for Cancer and Chemotherapy, Osaka University, Graduate School of Medicine, Suita, Osaka 565-0871, Japan.
Masaki MoriDepartment of Gastroenterological Surgery, Graduated School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Koh FurutaDivision of Clinical Laboratories, National Cancer Center Hospital, Chuo-ku Tokyo, 104-0045, Japan.
Takeshi NakajimaEndoscopy Division, National Cancer Center Hospital, Chuo-ku, Tokyo 104-0045, Japan.
Hiroshi HayashiR&D Department, SRL Inc., Hino-shi, Tokyo 191-0002, Japan.
Hajime SugisakiR&D Department, SRL Inc., Hino-shi, Tokyo 191-0002, Japan.
Hiroko HigashimotoR&D Department, SRL Inc., Hino-shi, Tokyo 191-0002, Japan.
Takashi KatoIntegrative Bioscience and Biomedical Engineering, Graduate School of Advanced Science and Engineering, Waseda University, Shinjuku, Tokyo 162-8480, Japan.
Fumitaka TakeshitaDivision of Molecular and Cellular Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo 104-0045, Japan.
Takahiro OchiyaDivision of Molecular and Cellular Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo 104-0045, Japan.
Osaka University · JPShionogi (Japan) · JPSRL (Japan) · JPNational Cancer Center Hospital East · JPWaseda University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer cells secrete small membranous extracellular vesicles (EVs) into their microenvironment and circulation. Although their potential as cancer biomarkers has been promising, the identification and quantification of EVs in clinical samples remains challenging. Here we describe a sensitive and rapid analytical technique for profiling circulating EVs directly from blood samples of patients with colorectal cancer. EVs are captured by two types of antibodies and are detected by photosensitizer-beads, which enables us to detect cancer-derived EVs without a purification step. We also show that circulating EVs can be used for detection of colorectal cancer using the antigen CD147, which is embedded in cancer-linked EVs. This work describes a new liquid biopsy technique to sensitively detect disease-specific circulating EVs and provides perspectives in translational medicine from the standpoint of diagnosis and therapy.

Indexed as

BasiginBiomarkers, TumorCase-Control StudiesColorectal NeoplasmsEnzyme-Linked Immunosorbent AssayExtracellular SpaceHT29 CellsHumansImmunoblottingSecretory VesiclesTetraspanin 28Tetraspanin 29Tetraspanin 30BasiginBiomarkers, TumorBSG protein, humanCD63 protein, humanCD81 protein, humanCD9 protein, humanTetraspanin 28Tetraspanin 29Tetraspanin 30

Identifiers

PMID24710016
PMCPMC3988821
OpenAlexW2034774921

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.